Up next

Autoplay

The Role of CGRP as Targeted Treatment for Migraine - Module 2: Ubrogepant

0 Views • 08/28/25
Share
Side Effects
Side Effects
Subscribers
0

Stewart J. Tepper, MD, provides his perspectives on the clinical impact of 4 recently published studies involving the management of patients with migraines.
This module covers the publication "A phase IIb, randomized, double-blind, placebo-controlled trial of ubrogepant for the acute treatment of migraine."
To view the entire activity, download resources and earn CE/CME credit, please visit www.annenberg.net

Show more
0 Comments sort Sort By

Up next

Autoplay